Wordt geladen...
The elusive CML stem cell: does it matter and how do we eliminate it?
CML is a clonal multistep myeloproliferative disease originating from and ultimately sustained by a rare population of BCR-ABL(+) cells with multilineage stem cell properties. Imatinib, the most successful of molecular targeted therapies, has revolutionized treatment of patients with CML. Despite th...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2948413/ https://ncbi.nlm.nih.gov/pubmed/20875553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2010.06.006 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|